MEDP Live signals | Maximize Profits with Getagraph.com

SELL 166 min ago

@ $383.62

Issued: 18 Apr 2024 @ 10:29

Return: -0.63%

Previous signal: Apr 18 - 09:31

Previous signal: Buy

Return: 1.15 %

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 13:15):

Stats
Today's Volume	95 223.00
Average Volume	253 480
Market Cap	11.73B
EPS	$0 ( 2024-02-12 )
Next earnings date	( $2.45 ) 2024-04-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	42.98
ATR14	$9.59 (2.51%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Kraft Robert O.	Buy	72	Common Stock
2024-03-31	Kraft Robert O.	Sell	72	Restricted Stock Unit
2024-03-31	Mccarthy Cornelius P. Iii	Buy	63	Common Stock
2024-03-31	Mccarthy Cornelius P. Iii	Sell	63	Restricted Stock Unit
2024-03-31	Carley Brian T	Buy	79	Common Stock

INSIDER POWER
-94.48
Last 100 transactions
Buy: 69 002 \| Sell: 2 472 032

Volume Correlation

Long: 0.04 (neutral)

Short: -0.97 (very strong negative)

Signal:(40) Neutral

Medpace Holdings Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Medpace Holdings Inc Correlation - Currency/Commodity

-0.58
( weak negative )

-0.39
( neutral )

-0.43
( neutral )

-0.45
( neutral )

0.05
( neutral )

-0.14
( neutral )

Medpace Holdings Inc Financials

Annual	2023
Revenue:	$1.89B
Gross Profit:	$524.51M (27.81 %)
EPS:	$9.20

Q4	2023
Revenue:	$498.40M
Gross Profit:	$136.81M (27.45 %)
EPS:	$2.55

Q3	2023
Revenue:	$492.50M
Gross Profit:	$133.19M (27.04 %)
EPS:	$2.30

Q2	2023
Revenue:	$460.87M
Gross Profit:	$124.32M (26.97 %)
EPS:	$2.00

Financial Reports:

No articles found.

Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Realtime updates for Medpace Holdings Inc [MEDP]

Upcoming Earnings Alert